1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIH Director's Early Independence Award (DP5 Clinical Trial Optional) is sponsored by NIH Common Fund, Office of Strategic Coordination. Part of the High-Risk, High-Reward Research program, this award supports promising, newly graduated scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period and launch independent research careers.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIH Director's Early Independence Award | NIH Common Fund NIH Director's Early Independence Award NIH Director's Early Independence Award FY2025 NIH Director’s Early Independence Award informational video Part of the High-Risk, High-Reward Research program, the NIH Director's Early Independence Award supports promising, newly graduated scientists with the intellect, scientific creativity, drive, and maturity bypass the traditional postdoctoral training period to launch independent research careers.
Part of the High-Risk, High-Reward Research program , the award supports promising, newly graduated scientists with the intellect, scientific creativity, drive, and maturity to bypass the traditional postdoctoral training period to launch independent research careers.
Recipient of terminal research degree or completed postgraduate clinical training within previous 16 months or expectation to do so within following 12 months of application submission date Must be in non-independent research position at time of application submission Limit of 2 applications per institution Preliminary data not required Requires 9.
6 months of research effort each year for first 2 years Requires 3-5 Letters of Reference $350,000 direct costs per year for up to 5 years See the Award Overview for more information. Applications due September 10, 2026.
Application & Award Guide Recent News & Announcements How Exercise Supports Memory – and How Scientists Hope to Replicate Its Benefits The Rugged Landscape of Enzymes and the Future of Medicine Seeing the Whole Picture: How Multi-Omics Is Transforming Genetic Diagnosis Technological Improvements Propel Kidney Disease Research Forward This page last reviewed on
According to the current listing, eligibility includes: Newly graduated scientists with a terminal research degree or who have completed postgraduate clinical training within the previous 16 months or expect to do so within the following 12 months of the application submissi…. Confirm the full requirements in the official notice before applying.
The current listing shows $350,000 direct costs per year for up to 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 10, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
NIH Director's Early Independence Award (DP5 Clinical Trial Optional) is funded by NIH Common Fund, Office of Strategic Coordination. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NOT-RM-26-004 asks the public for NIH-wide research challenges worth a 10-year, cross-institute program. There is no budget, no biosketch, no page limit, and no award. What there is: the five criteria every Common Fund investment has met since 2006, a new bullet about small-lab burden, and a fund whose FY 2026 request came in at $347.4 million — down 49.3 percent.
Read articleNIH's FY2026 omnibus adds a Phase IIB Strategic Breakthrough Award up to $30M — but it requires a 100% outside match. Here's who it's for and how to plan.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read article